Clinical Trial Update: Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers [Phase 2]

View source ↗

Summary

Phase 2 trial assessing immunogenicity, safety, and booster response when a rabies vaccine is given together with a Japanese encephalitis vaccine in toddlers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis
• Rabies

Drugs mentioned

• Japanese Encephalitis Vaccine (Japanese Encephalitis vaccine)
• Rabies vaccine (rabies vaccine)

Snippet

Sponsor: Novartis | Conditions: Rabies, Japanese Encephalitis | Phase 2 | Status: COMPLETED